EvlaBio AG is a biotech company, focused on the development of a therapy addressing a high unmet medical need in the cardiorenal space. Specifically, we are addressing Left Ventricular Hypertrophy (LVH) in the setting of chronic kidney disease, which affects millions of patients and for which there are limited treatment options.
| Website | https://www.evlabio.com |
| Employees | 4 (2 on RocketReach) |
| Founded | 2022 |
| Industry | Biotechnology |
| Keywords | Kidney Disease Treatment, Biotechnology, Heart Disease Treatment, Unmet Medical Needs, Clinical Stage Biotech, Biopharmaceutical, Therapeutic Drug Development, Preclinical Development, Novel Therapies, Pharmaceutical Research, Drug Discovery, Life Sciences, Regenerative Medicine, Medical Technology, Health Technology |
Looking for a particular EvlaBio AG employee's phone or email?
Thomas Kirmeier is the Co-founder and COO of EvlaBio AG.
2 people are employed at EvlaBio AG.